1. Advances in translational science to identify new therapies for systemic lupus erythematosus. Alberta Hoi and Fabien Vincent.2. Hallmark of systemic lupus erythematosus: Role of B Cell Hyperactivity. Fabien B Vincent, William A Figgett and Margaret L Hibbs.3. B cell targeted therapies in systemic lupus erythematosus. Fabien B Vincent1, William A Figgett and Margaret L Hibbs.4. Type I Interferons and the perpetuation of a loss of tolerance. Kathryn Connelly and Alberta Hoi.5. Therapeutic Modulation of the Interferon Pathway in Systemic Lupus Erythematosus. Shereen Oon.6. The concept of co-stimulatory blockade in SLE. Alberta Hoi.7. Cytokines: their role in amplifying SLE pathogenesis. Bonnia Liu and Alberta Hoi.8. Intracellular targets in SLE. Alberta Hoi.9. Regulatory T cells in SLE. Rachel Cheong and Joshua Ooi.10. Balancing strategies: GC and GILZ Axis. Champa Nataraja, Wendy Zhu, Wendy Dankers and Sarah A. Jones and Alberta Hoi.

About the Author: Associate Professor Alberta Hoi is a rheumatologist, leading lupus expert and translational researcher in Australia. Her research focusses on disease predictors and outcomes, registry design and implementation, quality of care and patient-centred interactions.
She has received her undergraduate medical degree from Melbourne University (1996), and completed a doctoral of philosophy in immunology on a NHMRC scholarship from Monash University. She is a fellow of the Royal Australasian College of Physician and member of the Australian Rheumatology Association (ARA). Her current clinical activities include seeing patients at Monash Lupus Clinic, where she serves as the Clinic Head, as well as Complex Rheumatology Clinic at Monash Health, and Autoimmune Clinic at Austin Health.
She is a chief investigator and senior research fellow at the Centre for Inflammatory Diseases, School of Clinical Sciences Monash University. She has developed core set measurements and studied factors that determine optimal outcomes in SLE, and she was pivotal in the successful roll out of the Australian Lupus Registry & Biobank, a national disease registry that serves as a valuable research resource, that foster collaboration between translational scientists and clinicians at national and international levels.
Associate Professor Alberta Hoi plays an active role in a number of investigator-initiated SLE studies and clinical trials. Currently she is the chair and custodian of the Australian Lupus Registry & Biobank Steering committee. She is also on the executive committee and a founding member of the Asia-Pacific Lupus Collaboration (APLC). She serves on an honorary basis as the treasurer for the Victorian branch ARA and the Australian Chinese Medical Association Victoria.